p53 Over-expression and its correlation with PCNA index in nasal polyps

Rhinology

Volumn 37, Issue 4, 1999, Pages 160-163

  Lavezzi, Anna ^b   Mantovani, Mario ^b   Cazzullo, Alessandra ^b   Turconi, Paola ^b   Matturri, Luigi ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

Epithelial cell proliferation; Immunohistochemistry nasal polyps p53 mutation; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE; PROTEIN P53;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NOSE POLYP; TUMOR GROWTH;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NASAL POLYPS; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033385222     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ahomadegbe JC, Barrois M, Fogel S, Le Bihan ML et al., (1995) High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 10:1217-1227.
2. Allred DC, Clark GM, Elledge R et al., (1993) Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85:200-206.
3. Battifora H (1994) p53 immunohistochemistry: a world of caution. Hum Pathol 25:435-437.
4. Caplin I, Haynes JT, Spahn J (1971) Are nasal polyps an allergic phenomenon? Ann Allergy 29:631-634.
5. Coste A, Rateau JG, Bernaudin JF, PeynËgre R, Escudier E (1996, a) Nasal polyposis pathogenesis: a flow cytometric and immunohistochemical study of epithelial cell proliferation. Acta Otolaryngol 116:755-761.
6. Coste A, Rateau JG, Roudot-Thoraval F, Chapelin C, Gilain L, Bernaudin JF, PeynËgre R, Escudier E (1996, b) Increased epithelial cell proliferation in nasal polyps. Arch Otolaryngol Head Neck Surg 122:432-436.
7. Coste A, Wang QP, Roudot-Thoraval F, Chapelin C, Bedbeder P, Poron F, PeynËgre R, Escudier E (1996, c) Epithelial cell proliferation in nasal polyps could be up-regulated by platelet-derived growth factor. Laryngoscope 106:578-583.
8. Fritsche M, Haessler C, Brandner G (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8:307-318.
9. Garcia RL, Coltrera MD, Gown AM (1989) Analysis of proliferative grade using anti PCNA/Cyclin in fixed embedded tissues. Am J Pathol 134:733-739.
10. Harris CC, Hollstein M (1993) Clinical implication of the p53 tumor-suppressor gene. N Engl J Med 329:1318-1327.
11. Kastan M, Onyekwere O, Sidransky D, Vogelstein B, Craig R (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311.
12. Kennedy SM, Macgeogh, Jaffe R, Spurr NK (1994) Over-expression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutations. Hum Pathol 25: 438-442.
13. Krajina Z (1963) A contribution to the aethiopathogenesis of nasal polyps. Pract oto-rhino-laryngol 25:241-246.
14. Kurki P, Vanderlaan M, Dolbeare F (1986) Expression of Proliferating Cell Nuelear Antigen (PCNA/Cyclin) during the cell cycle. Exp Cell Res 166:209-219.
15. Kusama K, Okutsu S, Takeda A, Himiya T et al., (1996) p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma. J Pathol 178:415-421.
16. Levine AJ, Momand J, Finlay CA (1991) The p53 tumors suppressor gene. Nature 351:453-456.
17. Levine AJ, Perry ME, Chang A et al., (1994) The role of the p53 tumor-suppressor gene in tumorigenesis. Br J Cancer 69:409-416.
18. Malkin D (1994) p53 mutation and cancer. Ann Rev Genet 28:443-465.
19. Maltzman W, Czyzyk L (1984) UV irradiation stimulates levels of p53 cellular tumor antigen in nontrasformed mouse cells. Mol Cell Biol 4:1689-1694.
20. Melhem MF, Law JC, el-Ashmawy L, Johnson JT et al., (1995) Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers. Am J Pathol 146:1170-1177.
21. Raybaud-Diogene H, Tetu B, Morency R et al., (1996) p53 overexpression in head and neck squamous cell carcinoma: review of the literature. Oral Oncol Eur J Cancer 32:143-149.
22. Samter M, Beers RF (1968) Intolerance to aspirin. Ann Intern Med 68:975-983.
23. Schwachman H, Kulezychi LL, Mueller HL, Flake CG (1962) Nasal polyps in patients with cystic fibrosis. Pediatrics 30:389-401.
24. Small P, Frenkiel S, Black M (1981) Multifactorial etiology of nasal polyps. Ann.Allergy 46: 317-320.
25. Smith ML, Chen IT, Zhan Q (1995) Involvement of the p53 tumor suppressor in repair of uv-type DNA damage. Oncogene 16:1053-1059.
26. Soussi T (1995) The p53 tumor suppressor gene. In: Genome Biology Genetics of Human Neoplasia. Verma RS, ed. Greenwich, Connecticut; JAI Press.
27. Tos M, Mogensen C (1977) Pathogenesis of nasal polyps. Rhynology 15:87-95.
28. Tos M, Larsen P (1990) Pathogenesis of nasal polyps. In: Rhinology Today. E. de Campora (Ed), Rome, pp: 119-128.
29. Yu C, Woods A, Levison D (1991) The application of immunohistochemistry in assessment of cellular proliferation. In: Assessment of Cell Proliferation in Clinical Practice. P.Hall, D.Levison, N.Wright, editors. Berlin: Springer-Verlag, pp:134-136.
30. Zambetti GP, Levine AJ (1993) A comparison of the biological activities of wild-type and mutant p53. FASEB J 7:855-865.